Doximity, Inc. (NASDAQ:DOCS) Shares Purchased by Corient Private Wealth LLC

Corient Private Wealth LLC boosted its stake in shares of Doximity, Inc. (NASDAQ:DOCS) by 3.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 8,887 shares of the company’s stock after buying an additional 334 shares during the quarter. Corient Private Wealth LLC’s holdings in Doximity were worth $474,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. FMR LLC increased its position in shares of Doximity by 30.5% in the third quarter. FMR LLC now owns 6,837,733 shares of the company’s stock valued at $297,920,000 after buying an additional 1,598,602 shares in the last quarter. Lord Abbett & CO. LLC acquired a new stake in Doximity in the 3rd quarter valued at about $29,453,000. Wilmington Savings Fund Society FSB purchased a new position in Doximity during the 3rd quarter valued at about $24,691,000. Geode Capital Management LLC raised its position in Doximity by 19.8% during the third quarter. Geode Capital Management LLC now owns 2,856,984 shares of the company’s stock worth $124,503,000 after acquiring an additional 472,565 shares during the last quarter. Finally, Retirement Systems of Alabama lifted its holdings in shares of Doximity by 254.3% in the third quarter. Retirement Systems of Alabama now owns 534,256 shares of the company’s stock valued at $23,278,000 after purchasing an additional 383,480 shares in the last quarter. 87.19% of the stock is currently owned by institutional investors and hedge funds.

Doximity Trading Down 3.6 %

Shares of DOCS opened at $58.40 on Friday. Doximity, Inc. has a twelve month low of $22.96 and a twelve month high of $85.21. The firm has a market capitalization of $10.90 billion, a P/E ratio of 58.40, a price-to-earnings-growth ratio of 4.10 and a beta of 1.34. The stock’s fifty day simple moving average is $65.48 and its 200 day simple moving average is $54.43.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on the company. Stephens started coverage on Doximity in a research report on Friday, December 20th. They set an “equal weight” rating and a $55.00 price objective for the company. Canaccord Genuity Group raised their price target on Doximity from $60.00 to $71.00 and gave the stock a “hold” rating in a research report on Friday, February 7th. Bank of America upped their price objective on Doximity from $54.00 to $57.00 and gave the company a “neutral” rating in a research report on Monday, January 6th. Piper Sandler upgraded Doximity from a “neutral” rating to an “overweight” rating and lifted their price objective for the stock from $31.00 to $78.00 in a research report on Friday, February 7th. Finally, The Goldman Sachs Group upped their target price on shares of Doximity from $58.00 to $80.00 and gave the company a “neutral” rating in a report on Monday, February 10th. Eleven analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $64.22.

Insider Transactions at Doximity

In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of the business’s stock in a transaction that occurred on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the completion of the sale, the director now directly owns 6,360 shares in the company, valued at $366,463.20. The trade was a 75.87 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 37.40% of the company’s stock.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.